 Connection
Liyen Loh to Gene Products, gag
This is a "connection" page, showing publications Liyen Loh has written about Gene Products, gag.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.720 |
|
|
|
-
Loh L, Reece JC, Fernandez CS, Alcantara S, Center R, Howard J, Purcell DF, Balamurali M, Petravic J, Davenport MP, Kent SJ. Complexity of the inoculum determines the rate of reversion of SIV Gag CD8 T cell mutant virus and outcome of infection. PLoS Pathog. 2009 Apr; 5(4):e1000378.
Score: 0.312
-
Loh L, Batten CJ, Petravic J, Davenport MP, Kent SJ. In vivo fitness costs of different Gag CD8 T-cell escape mutant simian-human immunodeficiency viruses for macaques. J Virol. 2007 May; 81(10):5418-22.
Score: 0.270
-
De Rose R, Fernandez CS, Smith MZ, Batten CJ, Alc?ntara S, Peut V, Rollman E, Loh L, Mason RD, Wilson K, Law MG, Handley AJ, Kent SJ. Control of viremia and prevention of AIDS following immunotherapy of SIV-infected macaques with peptide-pulsed blood. PLoS Pathog. 2008 May 02; 4(5):e1000055.
Score: 0.073
-
Reece J, Petravic J, Balamurali M, Loh L, Gooneratne S, De Rose R, Kent SJ, Davenport MP. An "escape clock" for estimating the turnover of SIV DNA in resting CD4? T cells. PLoS Pathog. 2012; 8(4):e1002615.
Score: 0.024
-
Reece JC, Loh L, Alcantara S, Fernandez CS, Stambas J, Sexton A, De Rose R, Petravic J, Davenport MP, Kent SJ. Timing of immune escape linked to success or failure of vaccination. PLoS One. 2010 Sep 16; 5(9).
Score: 0.022
-
De Rose R, Fernandez CS, Loh L, Peut V, Mason RD, Alcantara S, Reece J, Kent SJ. Delivery of immunotherapy with peptide-pulsed blood in macaques. Virology. 2008 Sep 01; 378(2):201-4.
Score: 0.019
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|